Product

Company

NCT00141947·2 sites·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Beersheva Mental Health Center

With

Age

18–60

Sex

ALL

Healthy volunteers

Not accepted

lipid abnormalities
leukopenia or neutropenia
organic brain damage (mental retardation)
alcohol or drug abuse
renal disease
hepatic dysfunction
history of pancreatitis
thyroid axis alterations
suicide attempt in past year
cataracts
systemic treatment with more than 15,000IU vitamin A daily
patients with known hypersensitivity to bexarotene or other components of the product
pregnant women

The record

StatusUnknown

PhasePhase 3

Taking part15

StartedSep 2005

UpdatedJul 24, 2013

Conditions

Where2

Clareo Health | Bexarotene Treatment in Schizophrenia